0001716076-18-000002.txt : 20180710 0001716076-18-000002.hdr.sgml : 20180710 20180710171927 ACCESSION NUMBER: 0001716076-18-000002 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20180710 DATE AS OF CHANGE: 20180710 EFFECTIVENESS DATE: 20180710 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Joi Scientific, Inc. CENTRAL INDEX KEY: 0001716076 IRS NUMBER: 460915157 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-316447 FILM NUMBER: 18947590 BUSINESS ADDRESS: STREET 1: SPACE LIFE SCIENCES LABORATORY STREET 2: 505 ODYSSEY WAY, SUITE 103 CITY: MERRITT ISLAND STATE: FL ZIP: 32953 BUSINESS PHONE: 209-787-3564 MAIL ADDRESS: STREET 1: SPACE LIFE SCIENCES LABORATORY STREET 2: 505 ODYSSEY WAY, SUITE 103 CITY: MERRITT ISLAND STATE: FL ZIP: 32953 FORMER COMPANY: FORMER CONFORMED NAME: Joi Scientific DATE OF NAME CHANGE: 20170901 D 1 primary_doc.xml X0708 D LIVE 0001716076 Joi Scientific, Inc. SPACE LIFE SCIENCES LABORATORY 505 ODYSSEY WAY, SUITE 103 MERRITT ISLAND FL FLORIDA 32953 209-787-3564 DELAWARE Joi Scientific Corporation true Gaetan Thomas Space Life Sciences Laboratory 505 Odyssey Way, Suite103 Merritt Island FL FLORIDA 32953 Director William McGill Space Life Sciences Laboratory 505 Odyssey Way, Suite 103 Merritt Island FL FLORIDA 32953 Director Dean Woodman Space Life Sciences Laboratory 505 Odyssey Way, Suite 103 Merritt Island FL FLORIDA 32953 Director Traver Kennedy Space Life Sciences Laboratory 505 Odyssey Way, Suite 103 Merritt Island FL FLORIDA 32953 Executive Officer Director Promoter Robert Koeneman Space Life Sciences Laboratory 505 Odyssey Way, Suite 103 Merritt Island FL FLORIDA 32953 Executive Officer Director Kurt Frahn Space Life Sciences Laboratory 505 Odyssey Way, Suite 103 Merritt Island FL FLORIDA 32953 Executive Officer Huw Jones Space Life Sciences Laboratory 505 Odyssey Way, Suite 103 Merritt Island FL FLORIDA 32953 Executive Officer Other Energy Decline to Disclose 06b false 2018-06-26 false true true false 250000 10000000 250000 9750000 false 1 0 0 0 true Offering proceeds will be utilized for working capital and general corporate expenses, including payment of salaries, expenses and fees to those listed in Item 3. The Company has voluntarily limited payments to such persons to a maximum of $300K annually. false Joi Scientific, Inc. /s/Kurt Frahn Kurt Frahn Chief Financial Officer 2018-07-10